BioLineRx and Hemispherian announced that two abstracts on GLIX1, a novel therapy for glioblastoma and other solid tumors, will be presented at the 31st Society for Neuro-Oncology Annual Meeting in November 2026. The presentations will cover preclinical studies and ongoing Phase 1/2a clinical trials evaluating GLIX1's effectiveness in treating high-grade glioma and TMZ-resistant tumors. This highlights progress in developing GLIX1 as a first-in-class oral TET2 activator targeting DNA damage response in cancer treatment. The event offers a platform to share advances and could accelerate clinical development and awareness of GLIX1's potential.
The story about BioLineRx and Hemispherian's GLIX1 presentations comes with this market context from Pluang's Health sector. Of 100 priced health-sector US stocks tradable on Pluang, 25 rose and 68 fell today. AMLX traded at USD 27.89 with a 1-day change of +1.68%, CTXR at USD 0.50 with 90% buy order activity, and CRSP at USD 51.54 with a 1-day change of -1.55%, as of Oct 08, 2026 18:11 WIB.
Dividend 15 Split Corp. has renewed its at-the-market (ATM) equity program, allowing it to issue shares to the public at prevailing market prices until November 7, 2028. This program replaces the previous one that ended in 2025 and enables the compan...
Fieldstone Bio, a synthetic biology company, was selected for the Mining Tech Accelerator program by Founders Factory and Rio Tinto. The program supports innovative technologies that improve mineral exploration and extraction, providing Fieldstone wi...
Beam Global has signed a definitive agreement to acquire ScoutDI, a company specializing in drone technology and AI-powered inspection software. The acquisition will enable Beam to manufacture ScoutDI's drone systems in the US and Europe, targeting i...
Grabar Law Office is investigating shareholder claims against four companies—Aardvark Therapeutics, Coastal Financial Corporation, Erasca, Inc., and New Era Energy & Digital—for alleged securities violations and breaches of fiduciary duties. The clai...
Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...
